EULAR 2026 | EXHIBITORS
The EULAR Congress will feature the following corporate partners participating in London through industry sessions, exhibition booths, dedicated hospitality or meeting spaces, and branding opportunities. Explore the list of participating partners below:
- AbbVie
- Adamo Srl
- Advanz Pharma
- Alexion, AstraZeneca Rare Disease
- Alfasigma
- Alpinion
- Amgen
- Argenx
- Artiva Bio
- AstraZeneca
- Autolus
- Avalyn
- Beeline Medicines
- Biogen
- BMJ
- BMS
- Boehringer Ingelheim
- Cabaletta Bio
- Canon
- Celltrion
- CESAS Medical
- Chugai
- Clinical and Experimental Rheumatology
- Croma
- CRISPR Therapeutics
- CSL
- Cullinan Therapeutics
- Edimark
- Eli Lilly
- Elsevier
- Esaote
- Fate Therapeutics
- First Tracks Biotherapeutics
- Fresenius Kabi
- GE Healthcare
- Gedeon Richter
- GSK
- Helmholtz
- Indero
- Johnson & Johnson
- Kyowa Kirin
- Medac
- Merck
- MoonLake
- MSD
- Nkarta
- Novartis
- Otsuka
- Penetrium Bioscience
- Pfizer
- Roche
- RX Connect
- Samsung
- Sandoz
- Sanofi
- Sanofi Regeneron
- Sobi
- Spyre Therapeutics
- Stada
- Takeda
- The Journal of Rheumatology
- ThermoFisher Scientific
- UCB
- Viatris
- Vor Bio
- Wisepress
- Xencor
- Xiralite
- Zenas BioPharma
- ZS Associates
EULAR would like to express its sincere gratitude to its partners, whose support helps to make the EULAR Congress possible.